• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Roxane’s Generic Flucytosine Receives Approval In US

    FDA

    Roxane`s Generic Rufinamide approved in US as an anticonvulsant medication

    FDA

    Roxane`s Generic Desvenlafaxine Succinate(204083) approved in US as antidepressant

    FDA

    Roxane`s Generic Desvenlafaxine Succinate(204082) approved in US as antidepressant

    FDA

    Roxane`s Generic Dutasteride approved in US for Symptomatic BPH In Men

    FDA

    Roxane`s Generic Methamphetamine HCl approved in US, hyperactivity disorder

    FDA

    Roxane`s Dolophine Hcl (Methadone Hcl) Receives Supplemental Approval in US For Opioid Withdrawal Symptoms

    FDA

    Roxane`s Generic Linezolid (100Mg/5Ml) Approved in US For Bacterial Infections

    FDA

    Roxane`s Generic Tapentadol (50,75 &100 Mg) Receives Tentative Approval in US For Pain

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.